Results 1 to 10 of about 6,743 (110)

Spectrum of Mortality from Circulatory Diseases in China from 2004 to 2015 [PDF]

, 2022
BackgroundTwo circulatory diseases, cardiovascular and cerebrovascular diseases have become the leading death causes in China, and their morbidity and mortality are still rising.
JIANG Shenyi, YU Xiaosong
core   +1 more source

Blood pressure targets for prevention of cognitive decline in patients with diabetes and hypertension: Design of the Blood Pressure Control Target in Diabetes (BPROAD) Cognitive Study 高血压目标对于预防糖尿病和高血压患者的认知下降:BPROAD认知研究的设计

Journal of Diabetes, Volume 15, Issue 12, Page 1041-1047, December 2023., 2023
Highlights The optimal blood pressure (BP) target in patients with type 2 diabetes mellitus (T2DM) for the management of cognitive decline remains unknown. The Blood Pressure Control Target in Diabetes (BPROAD) Cognitive Study was designed to determine whether intensive BP treatment (systolic BP <120 mm Hg) reduces risk of dementia and mild cognitive ...
The BPROAD Study Group, Guang Ning, Jiang He, Weiqing Wang, Yufang Bi, Dalong Zhu, Jiguang Wang, Shengdi Chen, Yu Xu, BPROAD coordinating team at Ruijin Hospital, Lawrence J. Appel, William C. Cushman, Vivian A. Fonseca, Jeff D. Williamson, David M. Reboussin, Yaling Han, Hongbing Shen, Minghui Zhao, Hui Wang   +18 more
wiley   +1 more source

A network meta‐analysis of association between cardiometabolic risk factors and COVID‐19 outcome severity 心血管代谢危险因素与COVID‐19严重程度关联的网络荟萃分析

Journal of Diabetes, Volume 15, Issue 11, Page 968-977, November 2023., 2023
Highlights Among 301 studies, diabetes mellitus was the most studied cardiometabolic risk factor. In the network meta‐analysis, cerebrovascular disease had the highest impact (relative risk [RR] 1.69; 95% CI, 1.65–1.73) on COVID‐19 outcomes compared to other cardiometabolic risk factors.
Alina Binbin Li, Bo Yang, Yufei Li, Rachel Huynh, Samuel Shim, Kenneth Lo, Jie Li, Andrew Zullo, Wen‐Chih Wu, Simin Liu   +9 more
wiley   +1 more source

The role of miRNAs carried by extracellular vesicles in type 2 diabetes and its complications 外泌体miRNA在2型糖尿病及其并发症中的作用

Journal of Diabetes, Volume 15, Issue 10, Page 838-852, October 2023., 2023
Highlights This review outlines the history of miRNA discovery and its major advances in the field of metabolism. We explore the roles of miRNAs in diabetes‐related cognitive impairment. We innovatively propose that miRNAs also act with a certain organ‐targeting specificity due to the organ‐targeting nature of extracellular vesicles, which may aid ...
Yining Chao, Tianwei Gu, Zhou Zhang, Tianyu Wu, Jin Wang, Yan Bi   +5 more
wiley   +1 more source

Effects of neprilysin and neprilysin inhibitors on glucose homeostasis: Controversial points and a promising arena 脑啡肽酶和脑啡肽酶抑制剂对葡萄糖稳态的影响:一个有争议的观点和有前景的领域

Journal of Diabetes, Volume 15, Issue 5, Page 397-408, May 2023., 2023
Highlights Neprilysin (NEP) inhibitors may lead to beneficial effects through inhibition of NEP, which involves impairment of glucose homeostasis through modulation of insulin resistance and the development of pancreatic β cell dysfunction as observed in type 2 diabetes mellitus.
Faisal Holil AlAnazi, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Athanasios Alexiou, Marios Papadakis, Hanan A. Ogaly, Yousef Abud Alanazi, Hebatallah M. Saad, Gaber El‐Saber Batiha   +8 more
wiley   +1 more source

Association of alcohol consumption with all‐cause mortality, new‐onset stroke, and coronary heart disease in patients with abnormal glucose metabolism—Findings from a 10‐year follow‐up of the REACTION study 糖代谢异常患者饮酒与全因死亡率、新发卒中以及冠心病的关系——来自REACTION研究10年随访的发现

Journal of Diabetes, Volume 15, Issue 4, Page 289-298, April 2023., 2023
Highlights This long‐term longitudinal study demonstrates the association between alcohol consumption and health outcomes in patients with abnormal glucose metabolism including type 2 diabetes mellitus and prediabetes. Occasional drinking (less than once a week) reduces the risk of all‐cause mortality, while heavy alcohol consumption (≥30 g/day for men
Mengzhao Cui, Fei Li, Xiaokun Gang, Yuan Gao, Xianchao Xiao, Gang Wang, Yujia Liu, Guixia Wang   +7 more
wiley   +1 more source

Developing a prediction model for all‐cause mortality risk among patients with type 2 diabetes mellitus in Shanghai, China 中国上海地区建立的2型糖尿病患者全因死亡风险预测模型

Journal of Diabetes, Volume 15, Issue 1, Page 27-35, January 2023., 2023
Highlights This study constructed the first 5‐year all‐cause mortality risk prediction model for patients with type 2 diabetes mellitus in south China. This well‐performing model, using highly accessible predictors collected in routine clinical settings, provides a powerful tool for clinicians to identify high‐risk diabetic patients.
Jiying Qi, Ping He, Huayan Yao, Yanbin Xue, Wen Sun, Ping Lu, Xiaohui Qi, Zizheng Zhang, Renjie Jing, Bin Cui, Guang Ning   +10 more
wiley   +1 more source

Health utilities in Chinese patients with coronary heart disease and impaired glucose tolerance (ACE): A longitudinal analysis of a randomized, double‐blind, placebo‐controlled trial 中国冠心病合并糖耐量异常患者的健康相关生活质量:一项随机、双盲、安慰剂对照试验的纵向分析

Journal of Diabetes, Volume 14, Issue 7, Page 455-464, July 2022., 2022
Highlights The Acarbose Cardiovascular Evaluation (ACE) trial assessed the effects of acarbose in patients with coronary heart disease (CHD) and impaired glucose tolerance (IGT) in China. Acarbose treatment did not impact on health‐related quality of life in ACE trial participants with CHD and IGT. Myocardial infarction (MI), stroke, heart failure, and
José Leal, Frauke Becker, Lee‐Ling Lim, Rury R. Holman, Alastair M. Gray   +4 more
wiley   +1 more source

Atherosclerotic disease burden after bariatric surgery in patients with obesity and type 2 diabetes 肥胖和2型糖尿病患者减肥手术后动脉粥样硬化疾病的负担

Journal of Diabetes, Volume 13, Issue 8, Page 640-647, August 2021., 2021
Highlights A nested, nationwide, propensity‐matched cohort study was carried out using the Clinical Practice Research Datalink with 1186 patients with no past history of ASCVD, half of whom had undergone bariatric surgery. Bariatric surgery was associated with improved ASCVD outcomes and lower mortality, highlighting a potential prognostic role of the ...
Maddalena Ardissino, Francesca Watson, Ravi Amin, Peter Collins, Osama Moussa, Sanjay Purkayastha, Imperial Obesity Study Group   +6 more
wiley   +1 more source

Research on Named Entity Recognition of Electronic Medical Records Based on RoBERTa and Radical‐Level Feature

Wireless Communications and Mobile Computing, Volume 2021, Issue 1, 2021., 2021
Clinical named entity recognition (CNER) identifies entities from unstructured medical records and classifies them into predefined categories. It is of great significance for follow‐up clinical studies. Most of the existing CNER methods fail to give enough thought to Chinese radical‐level characteristics and the specialty of the Chinese field.
Yue Wu, Jie Huang, Caie Xu, Huilin Zheng, Lei Zhang, Jian Wan, Honghao Gao   +6 more
wiley   +1 more source